Clinical Trial Update: Long-Term Follow-up Study for Multiple Myeloma Patients Who Received Study Treatment (Plerixafor or Placebo) in the AMD3100-3102 Study (NCT00103662).

View source ↗

Summary

Long-term follow-up study of multiple myeloma patients who received plerixafor or placebo in the AMD3100-3102 trial. The study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Mozobil (Plerixafor) (Plerixafor)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Multiple Myeloma, Autologous Transplantation | Status: COMPLETED